drugset / Trial / NCT01079702
Everolimus and Capecitabine in Patients With Advanced Malignancy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In the investigators study the investigators combine everolimus, administrated twice daily at a fixed total dose of 10 mg continuously with capecitabine administered bid for 14 days followed by 7 days rest. In this study, capecitabine will be dose escalated.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-04
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 500 mg/m2 | — |
| Subject | Everolimus | Small molecule | 10 mg | Oral |